<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82466">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02122848</url>
  </required_header>
  <id_info>
    <org_study_id>hsl 2013-48</org_study_id>
    <nct_id>NCT02122848</nct_id>
  </id_info>
  <brief_title>Exercise Tolerance in Patients With Decompensated Heart Failure</brief_title>
  <official_title>Effects of Bilevel Positive Airway Pressure on Exercise Tolerance in Patients With Decompensated Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Sirio-Libanes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Sirio-Libanes</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of airway bilevel positive pressure on
      the improvement of exercise tolerance in patients with decompensated heart failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure causes limitation of functional capacity and worsening of exercise tolerance.
      The airway pressure as adjuvant of cardiac rehabilitation has demonstrated improvement of
      functional capacity, decrease of respiratory work, increase of oxygenation and pulmonary
      compliance. Objective: to evaluate the effectiveness of the bilevel positive airway pressure
      (BILEVEL) in the increase of exercise tolerance in patients with decompensated heart
      failure. Method: this is a cross-over randomized clinical trial, with individuals who will
      undergo a submaximal progressive exercise test of the lower limbs with a cycle-ergometer
      using continuous positive airway pressure (CPAP) and BILEVEL in a random order. Patients
      will also be evaluated using a health related quality of life questionnaire, pulmonary
      function test, inspiratory muscle and peripheral muscle strength tests. Hypothesis: The
      increase in exercise tolerance might be greater during the use of BILEVEL.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Endurance time of exercise in cycle ergometer.</measure>
    <time_frame>4 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>4 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Dyspnea will be evaluated by means of the modified Borg scale before and after exercise.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Bilevel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention will be performed using BiLevel ventilation mode with EPAP=10 cmH2O and a IPAP which manages 6-8ml/kg tidal volume.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiLevel</intervention_name>
    <description>The intervention will be performed using BiLevel ventilation mode with EPAP=10 cmH2O and a IPAP which manages 6-8ml/kg tidal volume.</description>
    <arm_group_label>Bilevel</arm_group_label>
    <other_name>BiPAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects who has heart failure functional class II or III of New York heart
             association

          -  over 18 years

          -  non-smokers

          -  without cognitive or motor deficit

          -  without vasoactive drugs or low doses

          -  without recent acute myocardial myocardium  (&lt;1 year)

          -  without recent cardiac surgery (&lt;1 year)

          -  without pulmonary disease

          -  without bronchodilators

        Exclusion Criteria:

          -  unstable angina

          -  atrial fibrillation and atrioventricular block third degree

          -  frequent vomiting

          -  respiratory instability while collecting data
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wellington Yamaguti</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Sirio-Libanes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wellington Yamaguti</last_name>
    <phone>551131550393</phone>
    <email>wellington.psyamaguti@hsl.org.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Igor Moraes</last_name>
    <phone>551131550200</phone>
    <email>Igorgutierrezmoraes@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospitalsiriolibanes</name>
      <address>
        <city>SÃ£o Paulo</city>
        <zip>01308-050</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wellington Yamaguti</last_name>
      <phone>551131550393</phone>
      <email>wellington.psyamaguti@hsl.org.br</email>
    </contact>
    <contact_backup>
      <last_name>Igor Moraes</last_name>
      <phone>551131550200</phone>
      <email>Igorgutierrezmoraes@yahoo.com.br</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>April 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Sirio-Libanes</investigator_affiliation>
    <investigator_full_name>Wellington Yamaguti</investigator_full_name>
    <investigator_title>Wellington Pereira dos Santos Yamaguti</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Exercise tolerance</keyword>
  <keyword>Noninvasive ventilation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
